Anthony MS, Anderson JJB, Alekel DL. Association between soy and/or isoflavones and bone: evidence from epidemiologic studies. In: Gilani GS, Anderson JJB, editors. Phytoestrogens and health. Champaign: IL. AOCS Press; 2002. p.331-40.
Vitolins MZ, Anthony MS, Burke GL. Use of soy isoflavones as an alternative to traditional hormone replacement therapy. In: Gilani GS, Anderson JJB, editors. Phytoestrogens and health. Champaign: IL. AOCS Press; 2002. p.520-36.
Vitolins MZ, Anthony MS, Burke GL. Epidemiology of soy isoflavones and cardiovascular disease. In: Gilani GS, Anderson JJB, editors. Phytoestrogens and health. Champaign: IL. AOCS Press; 2002. p.260-7.
Anthony MS. Soy/isoflavones and risk factors for cardiovascular disease. In: Gilani GS, Anderson JJB, editors. Phytoestrogens and health. Champaign: IL. AOCS Press; 2002. p.268-89.
Clarkson TB, Anthony MS, Cline JM. Clinical efficacy of phytoestrogens - pharmacology/biology. In: Lobo RA, editors. Treatment of the postmenopausal woman. Philadelphia. Lippincott Williams & Wilkins; 1999. p.577-86.
Hughes CL, Cline JM, Williams JK, Anthony MS, Wagner JD, Clarkson TB. Dietary soy phytoestrogens and the health of menopausal women: Overview and evidence of cardioprotection from studies in nonhuman primates. In: Wren BG, editors. Progress in the management of the menopause. New York. Parthenon Publishing; 1997.
Clarkson TB, Jayo JM, Anthony MS. Individual differences in the susceptibility of nonhuman primates to diet-induced atherosclerosis. In: Crepaldi G, Gotto AM, Manzato E, Baggio G, editors. Atherosclerosis VII. Amsterdam. Elsevier Science Publishers BV; 1989. p.149-52.
Clarkson TB, Anthony MS, Prichard RW. The comparative pathology of nonhuman primate atherosclerosis. In: Malinow MR, Blaton VH, editors. Regression of atherosclerotic lesions. New York: NY. Plenum; 1984. p.61-78.